Biomedical Engineering Reference
In-Depth Information
140. Lee HS, Lee JH, Ahn GY, et al. Fractional photothermolysis for the treat-
ment of acne scars: a report of 27 Korean patients. J Dermatol Treat
2008; 19: 45-9.
141. Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Second-generation
1,500-nm fractional photothermolysis for the treatment of acne scars.
Dermatol Surg 2008; 34: 1327-32.
142. Cho SB, Lee JH, Choi MJ, Lee KY, Oh SH. Effi cacy of the fractional pho-
tothermolysis system with dynamic operating mode on acne scars and
enlarged facial pores. Dermatol Surg 2009; 35: 108-14.
143. Kim HJ, Kim TJ, Kwon YS, Park JM, Lee JH. Comparison of a 1,550 nm
erbium:glass fractional laser and a chemical reconstruction of skin scars
(CROSS) method in the treatment of acne scars: a simultaneous split-
face trial. Lasers Surg Med 2009; 41: 545-9.
144. Hu S, Chen MC, Lee MC, Yang LC, Keoprasom N. Fractional resurfacing
for the treatment of atrophic facial acne scars in Asian skin. Dermatol
Surg 2009; 35: 826-32.
145. Mahmoud BH, Srivastava D, Janiga JJ, et al. Safety and effi cacy of erbium-
doped yttrium aluminum garnet fractionated laser for treatment of acne
scars in Type IV to VI skin. Dermatol Surg 2010; 36: 602-9.
146. Laubach HJ, Tannous Z, Anderson RR, Manstein D. A histological evalu-
ation of the dermal effects after fractional photothermolysis treatment.
Laser Surg Med 2005; 36(S17): 86.
147. Behroozan DS, Goldberg LH, Glaich AS, et al. Fractional photothermol-
ysis for treatment of poikiloderma of Civatte. Dermatol Surg 2006; 32:
298-301.
148. Dainichi T, Kawaguchi A, Ueda S, et al. Skin tightening effect using frac-
tional laser treatment: I. A randomized half-side pilot study on faces of
patients with acne. Dermatol Surg 2010; 36: 66-70.
149. Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations
on the use of an erbium-doped 1,550-nm fractionated laser and its
applications in dermatologic surgery. Dermatol Surg 2010; 36: 461-9.
150. Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological char-
acterization of a novel ablative fractional resurfacing device. Lasers Surg
Med 2007; 39: 87-95.
151. Deng H, Yuan D, Yan CL, et al. A 2,940 nm fractional photothermolysis
laser in the treatment of acne scarring: a pilot study in China. J Drugs
Dermatol 2009; 8: 978-80.
152. Walgrave SE, Ortiz AE, MacFalls HT, et al. Evaluation of a novel frac-
tional resurfacing device for the treatment of acne scarring. Lasers Surg
Med 2009; 41: 122-7.
153. Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acne-
iform scarring with CO
2
ablative fractional resurfacing. Lasers Surg Med
2008; 40: 381-6.
154. Ortiz A, Elkeeb L, Truitt A, Tournas J, Zachary C. Evaluation of a novel
fractional resurfacing device for treatment of acne scarring. Lasers Surg
Med 2008; 79: 31.
155. Hale EK, Sukal S, Bernstein L, Chapas A, Geronemus G. Ablative frac-
tional resurfacings for the treatment of moderate to severe acne scarring.
Lasers Surg Med 2008; 80: 31.
156. Kim S, Cho KH. Clinical trial of dual treatment with an ablative frac-
tional laser and a nonablative laser for the treatment of acne scars in
Asian patients. Dermatol Surg 2009; 35: 1089-98.
157. Cho SB, Lee SJ, Kang JM, et al. The effi cacy and safety of 10,600-nm
carbon dioxide fractional laser for acne scars in Asian patients. Dermatol
Surg 2009; 35: 1955-61.
158. Shek SY, Ho SGY, Yu CS, et al. Fractional carbon dioxide laser (Active Fx)
for the treatment of acne scar in Asian skin. Lasers Surg Med 2008;
280: 84.
159. Cassuto DA, Scrimali L, Sirago P. Energy, pulse width and density: the
role of each parameter in microfractional CO
2
laser resurfacing. Lasers
Surg Med 2008; 75: 30.
160. Wang YS, Tay YK, Kwok C. Fractional ablative carbon dioxide laser in
the treatment of atrophic acne scarring in Asian patients: a pilot study.
J Cosmet Laser Ther 2010; 12: 61-4.
161. Cho SB, Lee SJ, Cho S, et al. Non-ablative 1,550-nm erbium-glass and
ablative 10,600-nm carbon dioxide fractional laser for acne scars: a ran-
domized split-face study with blinded response evaluation. J Eur Acad
Dermatol Venereol 2010; 24: 921-5.
162. Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphak-
deedecha R. Effi cacy and safety of a carbon-dioxide ablative fractional
resurfacing device for treatment of atrophic acne scars in Asians. J Am
Acad Dermatol 2010; 63: 274-83.
163. Kim S. Clinical trial of a pinpoint irradiation technique with the
CO
2
laser for the treatment of atrophic acne scars. J Cosmet Laser Ther
2008; 29: 1-4.
164. Hedelung L, Haak CS, Togsverd-Bo K, et al. Fractional CO
2
laser resur-
facing for atrophic acne scars: A randomized controlled trial with
blinded response evaluation. Lasers Surg Med 2012; 44: 447-52.
165. Biesman B. Fractional ablative resurfacing: complications. Lasers Surg
Med 2009; 41: 177-8.
166. Fife D, Fitzpatrick RE, Zachary CB. Complications of fractional CO
2
laser
resurfacing: four cases. Lasers Surg Med 2009; 41: 179-84.
167. Avram M, Tope W, Yu T, et al. Hypertrophic scarring of the neck follow-
ing ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med
2009; 41: 185-8.
168. Wolfram D, Tzankov A, Pulzl P, Riza-Katzer H. Hypertrophic scars and
keloids. review of their pathophysiology. risk factors, and therapeutic
management. Dermatol Surg 2009; 35: 171-81.
169. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther
2004; 17: 212-18.
170. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone,
5-Flurouracil and Pulsed Dye Laser for Treatment of Keloid and Hyper-
trophic Scars. Dermatol Surg 2006; 32: 907-15.
171. Hochman B, Locali RF, Matsuoka PK, Ferreira LM. Intralesional triam-
cinolone acetonide for keloid treatment: a systemic review. Aesth Plast
Surg 2008; 32: 705-9.
172. Sexton GB. Local injection of triamcinolone acetonide in the manage-
ment of certain skin conditions. preliminary report. Can Med Assoc J
1960; 83: 1379-81.
173. Hussain MA, Kuruppu L, Sarhadi N. Step-by-step guide of a technique
using dental cartridges for intra-lesional steroid injection to keloids.
Eur J Plast Surg 2011; 34: 307-9.
174. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-
based therapies, standard practices, and emerging methods. Aesthetic
Plast Surg 2007; 31: 468-92.
175. Butler PD, Longaker MT, Yang GP. Current progress in keloid research
and treatment. J Am Coll Surg 2008; 206: 731-41.
176. Kumar S, Singh RJ, Reed AM, et al. Cushing's syndrome after intra-artic-
ular and intradermal administration of triamcinolone acetonide in three
pediatric patients. Pediatrics 2004; 113: 1820-4.
177. Ritota PC, Lo AK. Cushing's syndrome in postburn children following
intralesional triamcinolone injection. Ann Plast Surg 1996; 36: 508-11.
178. Teelucksingh S, Balkaran B, Ganeshmoorthi A, et al. Prolonged child-
hood Cushing's syndrome secondary to intralesional triamcinolone ace-
tonide. Ann Trop Paediatr 2002; 22: 89-91.
179. Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intral-
esional injection of triamcinolone acetonide for the treatment of keloid
scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 2006; 40:
111-16; LEVEL B.
180. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995; 33: 117-23.
181. Darzi MA, Chowdri NA, Kaul SK, et al. Evaluation of various methods
of treating keloids and hypertrophic scars: a 10-year follow-up study.
Br J Plast Surg 1992; 45: 374-9.
182. Sherris DA, Larrabee WF Jr, Murakami CS. Management of scar con-
tractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am
1995; 28: 1057-68.
183. Lawrence WT. In search of the optimal treatment of keloids: report of a
series and a review of the literature. Ann Plast Surg 1998; 40: 490-3.
184. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in
keloids treated with kenacort. J Trauma 1995; 38: 299-302.
185. Tang YW. Intra- and postoperative steroid injections for keloids and
hypertrophic scars. Br J Plast Surg 1992; 45: 371-3.
186. Kiil J. Keloids treated with topical injections of triamcinolone acetonide
(kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg
1977; 11: 169-72.
187. Ardehali B, Nouraei SA, van Dam H, et al. Objective assessment of keloid
scars with three-dimensional imaging: Quantifying response to intrale-
sional steroid therapy. Plast Reconstr Surg 2007; 119: 556-61; LEVEL A.
188. Fitzpatrick RE. Treatment of infl ammed hypertrophic scars using intra-
lesional 5-FU. Dermatol Surg 1999; 25: 224-32.
189. Nanda S, Reddy BS. Intralesional 5-fl uorouracil as a treatment modality
of keloids. Dermatol Surg 2004; 30: 54-7.
190. Skuta GL, Parrish RK II. Wound healing in glaucoma fi ltering surgery.
Surv Ophthalmol 1987; 32: 149-70.
